Filter Results:
(2,549)
Show Results For
- All HBS Web
(2,549)
- People (11)
- News (681)
- Research (1,570)
- Events (8)
- Multimedia (3)
- Faculty Publications (932)
Show Results For
- All HBS Web
(2,549)
- People (11)
- News (681)
- Research (1,570)
- Events (8)
- Multimedia (3)
- Faculty Publications (932)
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
ultimately be bankrupt, and Americans will be forced to pay for a much higher share of their health care bills. There is a better way. The United States must make healthy living the twenty-first century equivalent of putting a man on the... View Details
Levels of Meaning
courses were even offered at HBS. But I decided to take Entrepreneurship and Global Capitalism (EGC) and The Coming of Managerial Capitalism because I wanted to balance “hard skills” courses with classes... View Details
- 06 Mar 2012
- First Look
First Look: March 6
U.S. corporations, which enjoy ready access to the deepest capital markets in the world. Venture capital, for example, and the public equity markets that support it, has channeled money to innovative ideas that have transformed industries... View Details
Keywords: Sean Silverthorne
Debra J. S. Fields
Capitalizing on the trend of upscale home baked goods, Fields began the company with one store in California in 1977 and, by 1984, had expanded to 160 stores in the United States and four international... View Details
Keywords: Food & Tobacco
- April 2004 (Revised March 2008)
- Case
Precise Software
By: Paul A. Gompers and Sara Bergson
Yossi Sela, general partner at Gemini Venture capital, considers a new investment in Precise Software. The firm is at a crisis point, and Sela needs to decide whether he will fire the firm's chief executive officer. Conflicts between the American CEO and the Israeli... View Details
Keywords: Venture Capital; Investment; Resignation and Termination; Crisis Management; Managerial Roles; Conflict and Resolution; Israel; United States
Gompers, Paul A., and Sara Bergson. "Precise Software." Harvard Business School Case 204-157, April 2004. (Revised March 2008.)
- 01 Dec 2002
- News
HBSAAA Conference Addresses Pathways to Power
the HBS community.” The enduring attraction of entrepreneurship informed a well-attended Venture Capital and Private Equity Summit that preceded the conference. Organized by Paula Groves (MBA '91) and Francine Starks (MBA '93), the... View Details
- 14 Jun 2004
- Research & Ideas
The Big Money for Big Projects
debt, which means the loan repayments must come from project cash flows only. In municipally financed or public financed projects, a government entity is the borrower or the debt is backed by a government guarantee. In the case of the Big Dig, the View Details
- 18 Feb 2002
- Research & Ideas
Wrap-up: Software, Telecom, and Recovery
According to experts at the conference session titled "From Bubble to Recession: The Current State of the Venture Capital Industry," none of the answers are simple, but a sense of perspective... View Details
- February 2014 (Revised March 2022)
- Case
School Specialty, Inc.
By: Stuart C. Gilson and Kristin Mugford
Set in 2013, School Specialty was a financially troubled supplier of educational products to primary and secondary schools in the United States. The company planned to file Chapter 11 in order to address its excessive debt load, but needed to arrange... View Details
Keywords: School Specialty; Bankruptcy; Section 363; Financing; Chapter 11; Capital Structure; Financing and Loans; Insolvency and Bankruptcy; Distribution Industry; Education Industry; United States
Gilson, Stuart C., and Kristin Mugford. "School Specialty, Inc." Harvard Business School Case 214-084, February 2014. (Revised March 2022.)
- Fast Answer
Insurance industry: companies and analysis
Where can I find information on the insurance industry? Best's Library Center: provides profiles of property, casualty, life and health insurance companies in the United States and Canada. View Details
- January 2000 (Revised November 2000)
- Case
Lucent Technologies New Ventures Group
By: Rosabeth M. Kanter and Michelle Heskett
Lucent Technologies' successful New Ventures Group must present company executives with a strong case for continuing corporate venturing activities despite a troubled financial performance in difficult market conditions. View Details
Keywords: Corporate Entrepreneurship; Business or Company Management; Management Teams; Business Ventures; Venture Capital; Financial Condition; Change Management; Wireless Technology; Financial Services Industry; Computer Industry; New Jersey
Kanter, Rosabeth M., and Michelle Heskett. "Lucent Technologies New Ventures Group." Harvard Business School Case 300-085, January 2000. (Revised November 2000.)
- 01 Jun 2012
- News
Jump-Start
using the Lean Startup methodology, for the 19 cash awards given out this year. There were also 12 venture capital firms (listed below) that stepped up to help fund the program run by HBS’s Arthur Rock Center for Entrepreneurship. All the... View Details
- 16 Mar 2010
- First Look
First Look: March 16
peripheral locations. If the goal of state and local policy makers is to encourage venture capital investment, outperformance of non-local investments suggests that policy makers might want to mitigate costs... View Details
Keywords: Martha Lagace
- Profile
Alex Slusky
started the program.” The best simulation of business experience Alex pursued the MBA because he had an interest in venture capital and wanted “to find a way to combine technology and strategy – how do we go up a level in business? Where... View Details
- October 2019
- Case
Impax Laboratories: Executing Accretive Acquisitions (A)
By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (A)." Harvard Business School Case 220-030, October 2019.
- 01 Sep 2007
- News
Getting Security Right
fifth-generation nuclear capabilities. The threat of nuclear aggression among powerful nations did not disappear with the Cold War; it remains a major challenge for the United States and poses a more serious danger than terrorism. The... View Details
- 23 Jul 2001
- Research & Ideas
How the Giants of Enterprise Seized the Future
desire, the demand, for high returns on invested capital can break down many a prejudice. That is the road the United States has been travelling—too slowly—since Carnegie's time. View Details
Keywords: by Richard S. Tedlow
James C. Donnell
Donnell expanded Ohio Oil’s reach to include 16 states and Mexico. Donnell established the Illinois Pipeline Corporation, capitalized at $20 million, to operate the pipeline transportation company of Ohio... View Details
Keywords: Utilities & Energy
- Web
Private Equity Finance - Course Catalog
equity and buyouts, also touching on closely related investing strategies such as distress and private debt. Students will examine a wide variety of investment settings: from lower middle market companies to mega-cap, from the United View Details
- October 2012
- Teaching Plan
Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech (TP)
By: Robert F. Higgins
This is the teaching note related to HBS case 808005. In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates... View Details
Keywords: Venture Philanthropy; Biotechnology; Funding Philanthropy Venture; Cystic Fibrosis; Foundations; Pharmaceuticals; Mergers and Acquisitions; For-Profit Firms; Venture Capital; Philanthropy and Charitable Giving; Science-Based Business; Nonprofit Organizations; Pharmaceutical Industry; Biotechnology Industry; United States; San Diego